Global Multivalent Influenza Vaccines Supply, Demand and Key Producers, 2023-2029

Page: 122

Published Date: 15 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Product Tags

Description

The global Multivalent Influenza Vaccines market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Multivalent Influenza Vaccines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Multivalent Influenza Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multivalent Influenza Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Multivalent Influenza Vaccines total production and demand, 2018-2029, (K Units)
Global Multivalent Influenza Vaccines total production value, 2018-2029, (USD Million)
Global Multivalent Influenza Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Multivalent Influenza Vaccines domestic production, consumption, key domestic manufacturers and share
Global Multivalent Influenza Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Multivalent Influenza Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Multivalent Influenza Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and Bcht Biotechnology, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Multivalent Influenza Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Multivalent Influenza Vaccines Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Multivalent Influenza Vaccines Market, Segmentation by Type
    Trivalent Inactivated Influenza Vaccine (IIV3)
    Trivalent Live Attenuated Vaccine (LAIV3)
    Quadrivalent Inactivated Influenza Vaccine (IIV4)

Global Multivalent Influenza Vaccines Market, Segmentation by Application
    6 Months to 3 Years
    Above 3 Years

Companies Profiled:
    Sanofi
    CSL
    GSK
    Viatris
    AstraZeneca
    Hualan Bio
    Changchun Institute of Biological
    Sinovac
    Bcht Biotechnology
    Jiangsu GDK
    KM Biologics
    ADIMMUNE Corporation
    Aleph Biomedical
    Shanghai Institute of Biological Products
    Zhongyianke Biotech
    Wuhan Institute of Biological Products

Key Questions Answered
1. How big is the global Multivalent Influenza Vaccines market?
2. What is the demand of the global Multivalent Influenza Vaccines market?
3. What is the year over year growth of the global Multivalent Influenza Vaccines market?
4. What is the production and production value of the global Multivalent Influenza Vaccines market?
5. Who are the key producers in the global Multivalent Influenza Vaccines market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Multivalent Influenza Vaccines Introduction
    1.2 World Multivalent Influenza Vaccines Supply & Forecast
        1.2.1 World Multivalent Influenza Vaccines Production Value (2018 & 2022 & 2029)
        1.2.2 World Multivalent Influenza Vaccines Production (2018-2029)
        1.2.3 World Multivalent Influenza Vaccines Pricing Trends (2018-2029)
    1.3 World Multivalent Influenza Vaccines Production by Region (Based on Production Site)
        1.3.1 World Multivalent Influenza Vaccines Production Value by Region (2018-2029)
        1.3.2 World Multivalent Influenza Vaccines Production by Region (2018-2029)
        1.3.3 World Multivalent Influenza Vaccines Average Price by Region (2018-2029)
        1.3.4 North America Multivalent Influenza Vaccines Production (2018-2029)
        1.3.5 Europe Multivalent Influenza Vaccines Production (2018-2029)
        1.3.6 China Multivalent Influenza Vaccines Production (2018-2029)
        1.3.7 Japan Multivalent Influenza Vaccines Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Multivalent Influenza Vaccines Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Multivalent Influenza Vaccines Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Multivalent Influenza Vaccines Demand (2018-2029)
    2.2 World Multivalent Influenza Vaccines Consumption by Region
        2.2.1 World Multivalent Influenza Vaccines Consumption by Region (2018-2023)
        2.2.2 World Multivalent Influenza Vaccines Consumption Forecast by Region (2024-2029)
    2.3 United States Multivalent Influenza Vaccines Consumption (2018-2029)
    2.4 China Multivalent Influenza Vaccines Consumption (2018-2029)
    2.5 Europe Multivalent Influenza Vaccines Consumption (2018-2029)
    2.6 Japan Multivalent Influenza Vaccines Consumption (2018-2029)
    2.7 South Korea Multivalent Influenza Vaccines Consumption (2018-2029)
    2.8 ASEAN Multivalent Influenza Vaccines Consumption (2018-2029)
    2.9 India Multivalent Influenza Vaccines Consumption (2018-2029)

3 World Multivalent Influenza Vaccines Manufacturers Competitive Analysis
    3.1 World Multivalent Influenza Vaccines Production Value by Manufacturer (2018-2023)
    3.2 World Multivalent Influenza Vaccines Production by Manufacturer (2018-2023)
    3.3 World Multivalent Influenza Vaccines Average Price by Manufacturer (2018-2023)
    3.4 Multivalent Influenza Vaccines Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Multivalent Influenza Vaccines Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Multivalent Influenza Vaccines in 2022
        3.5.3 Global Concentration Ratios (CR8) for Multivalent Influenza Vaccines in 2022
    3.6 Multivalent Influenza Vaccines Market: Overall Company Footprint Analysis
        3.6.1 Multivalent Influenza Vaccines Market: Region Footprint
        3.6.2 Multivalent Influenza Vaccines Market: Company Product Type Footprint
        3.6.3 Multivalent Influenza Vaccines Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Multivalent Influenza Vaccines Production Value Comparison
        4.1.1 United States VS China: Multivalent Influenza Vaccines Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Multivalent Influenza Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Multivalent Influenza Vaccines Production Comparison
        4.2.1 United States VS China: Multivalent Influenza Vaccines Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Multivalent Influenza Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Multivalent Influenza Vaccines Consumption Comparison
        4.3.1 United States VS China: Multivalent Influenza Vaccines Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Multivalent Influenza Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Multivalent Influenza Vaccines Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Multivalent Influenza Vaccines Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Multivalent Influenza Vaccines Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Multivalent Influenza Vaccines Production (2018-2023)
    4.5 China Based Multivalent Influenza Vaccines Manufacturers and Market Share
        4.5.1 China Based Multivalent Influenza Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Multivalent Influenza Vaccines Production Value (2018-2023)
        4.5.3 China Based Manufacturers Multivalent Influenza Vaccines Production (2018-2023)
    4.6 Rest of World Based Multivalent Influenza Vaccines Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Multivalent Influenza Vaccines Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Multivalent Influenza Vaccines Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Multivalent Influenza Vaccines Production (2018-2023)

5 Market Analysis by Type
    5.1 World Multivalent Influenza Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Trivalent Inactivated Influenza Vaccine (IIV3)
        5.2.2 Trivalent Live Attenuated Vaccine (LAIV3)
        5.2.3 Quadrivalent Inactivated Influenza Vaccine (IIV4)
    5.3 Market Segment by Type
        5.3.1 World Multivalent Influenza Vaccines Production by Type (2018-2029)
        5.3.2 World Multivalent Influenza Vaccines Production Value by Type (2018-2029)
        5.3.3 World Multivalent Influenza Vaccines Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Multivalent Influenza Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 6 Months to 3 Years
        6.2.2 Above 3 Years
    6.3 Market Segment by Application
        6.3.1 World Multivalent Influenza Vaccines Production by Application (2018-2029)
        6.3.2 World Multivalent Influenza Vaccines Production Value by Application (2018-2029)
        6.3.3 World Multivalent Influenza Vaccines Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Multivalent Influenza Vaccines Product and Services
        7.1.4 Sanofi Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Multivalent Influenza Vaccines Product and Services
        7.2.4 CSL Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 GSK
        7.3.1 GSK Details
        7.3.2 GSK Major Business
        7.3.3 GSK Multivalent Influenza Vaccines Product and Services
        7.3.4 GSK Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GSK Recent Developments/Updates
        7.3.6 GSK Competitive Strengths & Weaknesses
    7.4 Viatris
        7.4.1 Viatris Details
        7.4.2 Viatris Major Business
        7.4.3 Viatris Multivalent Influenza Vaccines Product and Services
        7.4.4 Viatris Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Viatris Recent Developments/Updates
        7.4.6 Viatris Competitive Strengths & Weaknesses
    7.5 AstraZeneca
        7.5.1 AstraZeneca Details
        7.5.2 AstraZeneca Major Business
        7.5.3 AstraZeneca Multivalent Influenza Vaccines Product and Services
        7.5.4 AstraZeneca Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 AstraZeneca Recent Developments/Updates
        7.5.6 AstraZeneca Competitive Strengths & Weaknesses
    7.6 Hualan Bio
        7.6.1 Hualan Bio Details
        7.6.2 Hualan Bio Major Business
        7.6.3 Hualan Bio Multivalent Influenza Vaccines Product and Services
        7.6.4 Hualan Bio Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Hualan Bio Recent Developments/Updates
        7.6.6 Hualan Bio Competitive Strengths & Weaknesses
    7.7 Changchun Institute of Biological
        7.7.1 Changchun Institute of Biological Details
        7.7.2 Changchun Institute of Biological Major Business
        7.7.3 Changchun Institute of Biological Multivalent Influenza Vaccines Product and Services
        7.7.4 Changchun Institute of Biological Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Changchun Institute of Biological Recent Developments/Updates
        7.7.6 Changchun Institute of Biological Competitive Strengths & Weaknesses
    7.8 Sinovac
        7.8.1 Sinovac Details
        7.8.2 Sinovac Major Business
        7.8.3 Sinovac Multivalent Influenza Vaccines Product and Services
        7.8.4 Sinovac Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Sinovac Recent Developments/Updates
        7.8.6 Sinovac Competitive Strengths & Weaknesses
    7.9 Bcht Biotechnology
        7.9.1 Bcht Biotechnology Details
        7.9.2 Bcht Biotechnology Major Business
        7.9.3 Bcht Biotechnology Multivalent Influenza Vaccines Product and Services
        7.9.4 Bcht Biotechnology Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Bcht Biotechnology Recent Developments/Updates
        7.9.6 Bcht Biotechnology Competitive Strengths & Weaknesses
    7.10 Jiangsu GDK
        7.10.1 Jiangsu GDK Details
        7.10.2 Jiangsu GDK Major Business
        7.10.3 Jiangsu GDK Multivalent Influenza Vaccines Product and Services
        7.10.4 Jiangsu GDK Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Jiangsu GDK Recent Developments/Updates
        7.10.6 Jiangsu GDK Competitive Strengths & Weaknesses
    7.11 KM Biologics
        7.11.1 KM Biologics Details
        7.11.2 KM Biologics Major Business
        7.11.3 KM Biologics Multivalent Influenza Vaccines Product and Services
        7.11.4 KM Biologics Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 KM Biologics Recent Developments/Updates
        7.11.6 KM Biologics Competitive Strengths & Weaknesses
    7.12 ADIMMUNE Corporation
        7.12.1 ADIMMUNE Corporation Details
        7.12.2 ADIMMUNE Corporation Major Business
        7.12.3 ADIMMUNE Corporation Multivalent Influenza Vaccines Product and Services
        7.12.4 ADIMMUNE Corporation Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 ADIMMUNE Corporation Recent Developments/Updates
        7.12.6 ADIMMUNE Corporation Competitive Strengths & Weaknesses
    7.13 Aleph Biomedical
        7.13.1 Aleph Biomedical Details
        7.13.2 Aleph Biomedical Major Business
        7.13.3 Aleph Biomedical Multivalent Influenza Vaccines Product and Services
        7.13.4 Aleph Biomedical Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Aleph Biomedical Recent Developments/Updates
        7.13.6 Aleph Biomedical Competitive Strengths & Weaknesses
    7.14 Shanghai Institute of Biological Products
        7.14.1 Shanghai Institute of Biological Products Details
        7.14.2 Shanghai Institute of Biological Products Major Business
        7.14.3 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product and Services
        7.14.4 Shanghai Institute of Biological Products Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Shanghai Institute of Biological Products Recent Developments/Updates
        7.14.6 Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
    7.15 Zhongyianke Biotech
        7.15.1 Zhongyianke Biotech Details
        7.15.2 Zhongyianke Biotech Major Business
        7.15.3 Zhongyianke Biotech Multivalent Influenza Vaccines Product and Services
        7.15.4 Zhongyianke Biotech Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Zhongyianke Biotech Recent Developments/Updates
        7.15.6 Zhongyianke Biotech Competitive Strengths & Weaknesses
    7.16 Wuhan Institute of Biological Products
        7.16.1 Wuhan Institute of Biological Products Details
        7.16.2 Wuhan Institute of Biological Products Major Business
        7.16.3 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product and Services
        7.16.4 Wuhan Institute of Biological Products Multivalent Influenza Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.16.5 Wuhan Institute of Biological Products Recent Developments/Updates
        7.16.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Multivalent Influenza Vaccines Industry Chain
    8.2 Multivalent Influenza Vaccines Upstream Analysis
        8.2.1 Multivalent Influenza Vaccines Core Raw Materials
        8.2.2 Main Manufacturers of Multivalent Influenza Vaccines Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Multivalent Influenza Vaccines Production Mode
    8.6 Multivalent Influenza Vaccines Procurement Model
    8.7 Multivalent Influenza Vaccines Industry Sales Model and Sales Channels
        8.7.1 Multivalent Influenza Vaccines Sales Model
        8.7.2 Multivalent Influenza Vaccines Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Multivalent Influenza Vaccines Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Multivalent Influenza Vaccines Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Multivalent Influenza Vaccines Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Multivalent Influenza Vaccines Production Value Market Share by Region (2018-2023)
    Table 5. World Multivalent Influenza Vaccines Production Value Market Share by Region (2024-2029)
    Table 6. World Multivalent Influenza Vaccines Production by Region (2018-2023) & (K Units)
    Table 7. World Multivalent Influenza Vaccines Production by Region (2024-2029) & (K Units)
    Table 8. World Multivalent Influenza Vaccines Production Market Share by Region (2018-2023)
    Table 9. World Multivalent Influenza Vaccines Production Market Share by Region (2024-2029)
    Table 10. World Multivalent Influenza Vaccines Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Multivalent Influenza Vaccines Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Multivalent Influenza Vaccines Major Market Trends
    Table 13. World Multivalent Influenza Vaccines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Multivalent Influenza Vaccines Consumption by Region (2018-2023) & (K Units)
    Table 15. World Multivalent Influenza Vaccines Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Multivalent Influenza Vaccines Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Multivalent Influenza Vaccines Producers in 2022
    Table 18. World Multivalent Influenza Vaccines Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Multivalent Influenza Vaccines Producers in 2022
    Table 20. World Multivalent Influenza Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Multivalent Influenza Vaccines Company Evaluation Quadrant
    Table 22. World Multivalent Influenza Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Multivalent Influenza Vaccines Production Site of Key Manufacturer
    Table 24. Multivalent Influenza Vaccines Market: Company Product Type Footprint
    Table 25. Multivalent Influenza Vaccines Market: Company Product Application Footprint
    Table 26. Multivalent Influenza Vaccines Competitive Factors
    Table 27. Multivalent Influenza Vaccines New Entrant and Capacity Expansion Plans
    Table 28. Multivalent Influenza Vaccines Mergers & Acquisitions Activity
    Table 29. United States VS China Multivalent Influenza Vaccines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Multivalent Influenza Vaccines Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Multivalent Influenza Vaccines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Multivalent Influenza Vaccines Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Multivalent Influenza Vaccines Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Multivalent Influenza Vaccines Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Multivalent Influenza Vaccines Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Multivalent Influenza Vaccines Production Market Share (2018-2023)
    Table 37. China Based Multivalent Influenza Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Multivalent Influenza Vaccines Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Multivalent Influenza Vaccines Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Multivalent Influenza Vaccines Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Multivalent Influenza Vaccines Production Market Share (2018-2023)
    Table 42. Rest of World Based Multivalent Influenza Vaccines Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Multivalent Influenza Vaccines Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Multivalent Influenza Vaccines Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Multivalent Influenza Vaccines Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Multivalent Influenza Vaccines Production Market Share (2018-2023)
    Table 47. World Multivalent Influenza Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Multivalent Influenza Vaccines Production by Type (2018-2023) & (K Units)
    Table 49. World Multivalent Influenza Vaccines Production by Type (2024-2029) & (K Units)
    Table 50. World Multivalent Influenza Vaccines Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Multivalent Influenza Vaccines Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Multivalent Influenza Vaccines Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Multivalent Influenza Vaccines Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Multivalent Influenza Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Multivalent Influenza Vaccines Production by Application (2018-2023) & (K Units)
    Table 56. World Multivalent Influenza Vaccines Production by Application (2024-2029) & (K Units)
    Table 57. World Multivalent Influenza Vaccines Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Multivalent Influenza Vaccines Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Multivalent Influenza Vaccines Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Multivalent Influenza Vaccines Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Major Business
    Table 63. Sanofi Multivalent Influenza Vaccines Product and Services
    Table 64. Sanofi Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Sanofi Recent Developments/Updates
    Table 66. Sanofi Competitive Strengths & Weaknesses
    Table 67. CSL Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Major Business
    Table 69. CSL Multivalent Influenza Vaccines Product and Services
    Table 70. CSL Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. CSL Recent Developments/Updates
    Table 72. CSL Competitive Strengths & Weaknesses
    Table 73. GSK Basic Information, Manufacturing Base and Competitors
    Table 74. GSK Major Business
    Table 75. GSK Multivalent Influenza Vaccines Product and Services
    Table 76. GSK Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GSK Recent Developments/Updates
    Table 78. GSK Competitive Strengths & Weaknesses
    Table 79. Viatris Basic Information, Manufacturing Base and Competitors
    Table 80. Viatris Major Business
    Table 81. Viatris Multivalent Influenza Vaccines Product and Services
    Table 82. Viatris Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Viatris Recent Developments/Updates
    Table 84. Viatris Competitive Strengths & Weaknesses
    Table 85. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 86. AstraZeneca Major Business
    Table 87. AstraZeneca Multivalent Influenza Vaccines Product and Services
    Table 88. AstraZeneca Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. AstraZeneca Recent Developments/Updates
    Table 90. AstraZeneca Competitive Strengths & Weaknesses
    Table 91. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 92. Hualan Bio Major Business
    Table 93. Hualan Bio Multivalent Influenza Vaccines Product and Services
    Table 94. Hualan Bio Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Hualan Bio Recent Developments/Updates
    Table 96. Hualan Bio Competitive Strengths & Weaknesses
    Table 97. Changchun Institute of Biological Basic Information, Manufacturing Base and Competitors
    Table 98. Changchun Institute of Biological Major Business
    Table 99. Changchun Institute of Biological Multivalent Influenza Vaccines Product and Services
    Table 100. Changchun Institute of Biological Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Changchun Institute of Biological Recent Developments/Updates
    Table 102. Changchun Institute of Biological Competitive Strengths & Weaknesses
    Table 103. Sinovac Basic Information, Manufacturing Base and Competitors
    Table 104. Sinovac Major Business
    Table 105. Sinovac Multivalent Influenza Vaccines Product and Services
    Table 106. Sinovac Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Sinovac Recent Developments/Updates
    Table 108. Sinovac Competitive Strengths & Weaknesses
    Table 109. Bcht Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 110. Bcht Biotechnology Major Business
    Table 111. Bcht Biotechnology Multivalent Influenza Vaccines Product and Services
    Table 112. Bcht Biotechnology Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Bcht Biotechnology Recent Developments/Updates
    Table 114. Bcht Biotechnology Competitive Strengths & Weaknesses
    Table 115. Jiangsu GDK Basic Information, Manufacturing Base and Competitors
    Table 116. Jiangsu GDK Major Business
    Table 117. Jiangsu GDK Multivalent Influenza Vaccines Product and Services
    Table 118. Jiangsu GDK Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Jiangsu GDK Recent Developments/Updates
    Table 120. Jiangsu GDK Competitive Strengths & Weaknesses
    Table 121. KM Biologics Basic Information, Manufacturing Base and Competitors
    Table 122. KM Biologics Major Business
    Table 123. KM Biologics Multivalent Influenza Vaccines Product and Services
    Table 124. KM Biologics Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. KM Biologics Recent Developments/Updates
    Table 126. KM Biologics Competitive Strengths & Weaknesses
    Table 127. ADIMMUNE Corporation Basic Information, Manufacturing Base and Competitors
    Table 128. ADIMMUNE Corporation Major Business
    Table 129. ADIMMUNE Corporation Multivalent Influenza Vaccines Product and Services
    Table 130. ADIMMUNE Corporation Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. ADIMMUNE Corporation Recent Developments/Updates
    Table 132. ADIMMUNE Corporation Competitive Strengths & Weaknesses
    Table 133. Aleph Biomedical Basic Information, Manufacturing Base and Competitors
    Table 134. Aleph Biomedical Major Business
    Table 135. Aleph Biomedical Multivalent Influenza Vaccines Product and Services
    Table 136. Aleph Biomedical Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Aleph Biomedical Recent Developments/Updates
    Table 138. Aleph Biomedical Competitive Strengths & Weaknesses
    Table 139. Shanghai Institute of Biological Products Basic Information, Manufacturing Base and Competitors
    Table 140. Shanghai Institute of Biological Products Major Business
    Table 141. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Product and Services
    Table 142. Shanghai Institute of Biological Products Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Shanghai Institute of Biological Products Recent Developments/Updates
    Table 144. Shanghai Institute of Biological Products Competitive Strengths & Weaknesses
    Table 145. Zhongyianke Biotech Basic Information, Manufacturing Base and Competitors
    Table 146. Zhongyianke Biotech Major Business
    Table 147. Zhongyianke Biotech Multivalent Influenza Vaccines Product and Services
    Table 148. Zhongyianke Biotech Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 149. Zhongyianke Biotech Recent Developments/Updates
    Table 150. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
    Table 151. Wuhan Institute of Biological Products Major Business
    Table 152. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Product and Services
    Table 153. Wuhan Institute of Biological Products Multivalent Influenza Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 154. Global Key Players of Multivalent Influenza Vaccines Upstream (Raw Materials)
    Table 155. Multivalent Influenza Vaccines Typical Customers
    Table 156. Multivalent Influenza Vaccines Typical Distributors
List of Figure
    Figure 1. Multivalent Influenza Vaccines Picture
    Figure 2. World Multivalent Influenza Vaccines Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Multivalent Influenza Vaccines Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Multivalent Influenza Vaccines Production (2018-2029) & (K Units)
    Figure 5. World Multivalent Influenza Vaccines Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Multivalent Influenza Vaccines Production Value Market Share by Region (2018-2029)
    Figure 7. World Multivalent Influenza Vaccines Production Market Share by Region (2018-2029)
    Figure 8. North America Multivalent Influenza Vaccines Production (2018-2029) & (K Units)
    Figure 9. Europe Multivalent Influenza Vaccines Production (2018-2029) & (K Units)
    Figure 10. China Multivalent Influenza Vaccines Production (2018-2029) & (K Units)
    Figure 11. Japan Multivalent Influenza Vaccines Production (2018-2029) & (K Units)
    Figure 12. Multivalent Influenza Vaccines Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Multivalent Influenza Vaccines Consumption (2018-2029) & (K Units)
    Figure 15. World Multivalent Influenza Vaccines Consumption Market Share by Region (2018-2029)
    Figure 16. United States Multivalent Influenza Vaccines Consumption (2018-2029) & (K Units)
    Figure 17. China Multivalent Influenza Vaccines Consumption (2018-2029) & (K Units)
    Figure 18. Europe Multivalent Influenza Vaccines Consumption (2018-2029) & (K Units)
    Figure 19. Japan Multivalent Influenza Vaccines Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Multivalent Influenza Vaccines Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Multivalent Influenza Vaccines Consumption (2018-2029) & (K Units)
    Figure 22. India Multivalent Influenza Vaccines Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Multivalent Influenza Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Multivalent Influenza Vaccines Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Multivalent Influenza Vaccines Markets in 2022
    Figure 26. United States VS China: Multivalent Influenza Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Multivalent Influenza Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Multivalent Influenza Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Multivalent Influenza Vaccines Production Market Share 2022
    Figure 30. China Based Manufacturers Multivalent Influenza Vaccines Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Multivalent Influenza Vaccines Production Market Share 2022
    Figure 32. World Multivalent Influenza Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Multivalent Influenza Vaccines Production Value Market Share by Type in 2022
    Figure 34. Trivalent Inactivated Influenza Vaccine (IIV3)
    Figure 35. Trivalent Live Attenuated Vaccine (LAIV3)
    Figure 36. Quadrivalent Inactivated Influenza Vaccine (IIV4)
    Figure 37. World Multivalent Influenza Vaccines Production Market Share by Type (2018-2029)
    Figure 38. World Multivalent Influenza Vaccines Production Value Market Share by Type (2018-2029)
    Figure 39. World Multivalent Influenza Vaccines Average Price by Type (2018-2029) & (US$/Unit)
    Figure 40. World Multivalent Influenza Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 41. World Multivalent Influenza Vaccines Production Value Market Share by Application in 2022
    Figure 42. 6 Months to 3 Years
    Figure 43. Above 3 Years
    Figure 44. World Multivalent Influenza Vaccines Production Market Share by Application (2018-2029)
    Figure 45. World Multivalent Influenza Vaccines Production Value Market Share by Application (2018-2029)
    Figure 46. World Multivalent Influenza Vaccines Average Price by Application (2018-2029) & (US$/Unit)
    Figure 47. Multivalent Influenza Vaccines Industry Chain
    Figure 48. Multivalent Influenza Vaccines Procurement Model
    Figure 49. Multivalent Influenza Vaccines Sales Model
    Figure 50. Multivalent Influenza Vaccines Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Product Tags

Multivalent Influenza Vaccines

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>